I.G. Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | $3.93M | Hold |
28,000
| – | – | 0.02% | 214 |
|
|
2017
Q2 | $3.41M | Buy |
28,000
+15,000
| +115% | +$1.83M | 0.02% | 231 |
|
|
2017
Q1 | $1.58M | Buy |
+13,000
| New | +$1.58M | 0.01% | 283 |
|
|
2016
Q4 | – | Sell |
-21,290
| Closed | -$2.61M | – | 793 |
|
|
2016
Q3 | $2.61M | Sell |
21,290
-31,166
| -59% | -$3.82M | 0.01% | 469 |
|
|
2016
Q2 | $6.13M | Buy |
52,456
+20,890
| +66% | +$2.44M | 0.02% | 348 |
|
|
2016
Q1 | $4.4M | Sell |
31,566
-184
| -0.6% | -$25.6K | 0.02% | 389 |
|
|
2015
Q4 | $6.06M | Buy |
31,750
+1,410
| +5% | +$269K | 0.03% | 315 |
|
|
2015
Q3 | $4.75M | Buy |
30,340
+19,165
| +171% | +$3M | 0.02% | 339 |
|
|
2015
Q2 | $2.02M | Buy |
11,175
+2,490
| +29% | +$450K | 0.01% | 512 |
|
|
2015
Q1 | $1.51M | Buy |
+8,685
| New | +$1.51M | 0.01% | 558 |
|
|
2014
Q1 | – | Sell |
-10,880
| Closed | -$1.45M | – | 887 |
|
|
2013
Q4 | $1.45M | Sell |
10,880
-6,860
| -39% | -$913K | 0.01% | 500 |
|
|
2013
Q3 | $2.06M | Buy |
17,740
+4,330
| +32% | +$503K | 0.01% | 452 |
|
|
2013
Q2 | $1.24M | Buy |
+13,410
| New | +$1.24M | 0.01% | 521 |
|